|
Telangana government has announced unprecedented progress in the life sciences sector, securing over Rs. 36,000 crore in investments from over 140 projects over the last one year. These investments are set to create 51,000 direct jobs and an estimated 1,50,000 indirect jobs, solidifying Telangana's status as a powerhouse in the global life sciences industry.
Speaking on the state’s achievements, minister for industries and commerce, Duddilla Sridhar Babu, highlighted that Telangana has become a focal point for both international and domestic life sciences companies, with Hyderabad serving as the epicenter for innovation.
“We have witnessed a surge of investments from several international and domestic companies, who have chosen Telangana as their gateway to India's rapidly growing life sciences ecosystem. From pharmaceutical manufacturing and R&D centres to GCC innovation hubs, these investments across the life sciences value chain make Telangana an undisputed leader in this space globally. This momentum not only includes significant investments from new entrants but also additional investments by companies that have already seen the value in expanding in Telangana. This is a strong indicator of their trust in present Government’s business friendly approach that we have championed over the last one year and the strong ecosystem built over the last 2-3 decades,” he said.
The heart of government strategy lies Genome Valley, India’s first and largest organized R&D cluster, which continues to attract industry leaders and pioneering research organizations. Another area that the government is excited about is the intersection of life sciences and technology. Hyderabad offers a deep talent pool with expertise in pharmaceuticals, biotechnology, AI / ML, data analytics, and digital health. With these extraordinary strengths, Hyderabad has created a niche for itself, as the hotspot for lifesciences and healthcare Global Capability Centres (GCCs).
“We are proud that these investments highlight our ability to attract companies across the lifesciences and healthcare value chain that include pharma, biotech, medtech, healthcare providers and health insurance players. This is a result of our efforts to proactively reach-out to these global companies aggressively showcasing Hyderabad as a preferred destination.
We are also happy to share that we will shortly introduce a dedicated life sciences policy, which will further streamline processes, attract investments, foster innovation, and drive sustainable growth across this critical sector. This upcoming policy is designed to address the evolving needs of the life sciences industry, ensuring Telangana consolidates its position as an important node in the global life sciences value chain,” said minister Babu.
|